Optiscan Imaging 과거 수익 실적

과거 기준 확인 0/6

Optiscan Imaging의 수입은 연평균 -25.8%의 비율로 감소해 온 반면, Medical Equipment 산업은 수입이 연평균 8.3%의 비율로 증가했습니다. 매출은 연평균 11.2%의 비율로 증가해 왔습니다.

주요 정보

-25.8%

수익 성장률

-14.5%

EPS 성장률

Medical Equipment 산업 성장	5.8%
매출 성장률	11.2%
자기자본 수익률	-43.7%
순이익	-203.0%
최근 수익 업데이트	30 Jun 2024

최근 과거 실적 업데이트

Recent updates

Here's Why We're Not Too Worried About Optiscan Imaging's (ASX:OIL) Cash Burn Situation

Sep 27

Can You Imagine How Jubilant Optiscan Imaging's (ASX:OIL) Shareholders Feel About Its 253% Share Price Gain?

Dec 02

수익 및 비용 분석

Optiscan Imaging 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

ASX:OIL 수익, 비용 및 수입 (AUD Millions )
날짜	수익	수익	G+A 비용	R&D 비용
30 Jun 24	3	-6	5	4
31 Mar 24	3	-6	4	4
31 Dec 23	2	-5	1	3
30 Sep 23	2	-5	0	3
30 Jun 23	3	-4	4	2
31 Mar 23	2	-5	2	2
31 Dec 22	2	-5	1	2
30 Sep 22	2	-4	1	2
30 Jun 22	2	-4	0	2
31 Mar 22	2	-4	1	2
31 Dec 21	3	-3	2	2
30 Sep 21	2	-3	2	2
30 Jun 21	2	-2	1	2
31 Mar 21	2	-2	1	2
31 Dec 20	2	-1	1	1
30 Sep 20	2	-2	1	1
30 Jun 20	2	-2	1	1
31 Mar 20	2	-2	1	1
31 Dec 19	1	-2	2	1
30 Sep 19	1	-2	2	1
30 Jun 19	1	-2	2	1
31 Mar 19	2	-2	1	1
31 Dec 18	2	-2	1	2
30 Sep 18	3	-2	1	2
30 Jun 18	3	-2	2	2
31 Mar 18	3	-2	2	2
31 Dec 17	2	-2	2	2
30 Sep 17	2	-2	2	2
30 Jun 17	1	-3	2	2
31 Mar 17	1	-3	2	2
31 Dec 16	1	-3	2	1
30 Sep 16	0	-2	2	1
30 Jun 16	0	-1	1	1
31 Mar 16	0	-1	1	1
31 Dec 15	0	-1	1	1
30 Sep 15	0	-1	1	1
30 Jun 15	0	-1	1	1
31 Mar 15	0	-1	1	1
31 Dec 14	0	-1	1	1
30 Sep 14	0	-1	1	1
30 Jun 14	0	-1	1	1
31 Mar 14	0	-2	1	1
31 Dec 13	0	-2	1	1

양질의 수익: OIL 은(는) 현재 수익성이 없습니다.

이익 마진 증가: OIL 은(는) 현재 수익성이 없습니다.

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: OIL 은(는) 수익성이 없으며 지난 5년 동안 연간 25.8% 비율로 손실이 증가했습니다.

성장 가속화: 현재 수익성이 없기 때문에 OIL 의 지난 1년 동안의 수익 성장을 5년 평균과 비교할 수 없습니다.

수익 대 산업: OIL 은(는) 수익성이 없어 지난 해 수익 성장을 Medical Equipment 업계( 18.7% )와 비교하기 어렵습니다.

자기자본 수익률

높은 ROE: OIL 현재 수익성이 없기 때문에 마이너스 자본 수익률( -43.7% )을 갖습니다.

Optiscan Imaging 과거 수익 실적

과거 기준 확인 0/6

주요 정보

최근 과거 실적 업데이트

Full year 2024 earnings released: AU$0.007 loss per share (vs AU$0.007 loss in FY 2023)

Full year 2023 earnings released: AU$0.007 loss per share (vs AU$0.007 loss in FY 2022)

First half 2023 earnings released: AU$0.004 loss per share (vs AU$0.003 loss in 1H 2022)

Full year 2022 earnings released: AU$0.007 loss per share (vs AU$0.004 loss in FY 2021)

Full year 2021 earnings released: AU$0.004 loss per share (vs AU$0.004 loss in FY 2020)

Full year earnings released - AU$0.0037 loss per share

Recent updates

Optiscan Imaging Limited, Annual General Meeting, Nov 21, 2024

Here's Why We're Not Too Worried About Optiscan Imaging's (ASX:OIL) Cash Burn Situation

New minor risk - Market cap size

Full year 2024 earnings released: AU$0.007 loss per share (vs AU$0.007 loss in FY 2023)

New minor risk - Share price stability

Optiscan Imaging Limited Appoints Brendan Fafiani to the Role of Chief Operating Officer, Effective 6 November 2023

Full year 2023 earnings released: AU$0.007 loss per share (vs AU$0.007 loss in FY 2022)

Optiscan Imaging Limited, Annual General Meeting, Nov 23, 2023

New minor risk - Financial data availability

New minor risk - Shareholder dilution

First half 2023 earnings released: AU$0.004 loss per share (vs AU$0.003 loss in 1H 2022)

We're Keeping An Eye On Optiscan Imaging's (ASX:OIL) Cash Burn Rate

Less than half of directors are independent

We're Keeping An Eye On Optiscan Imaging's (ASX:OIL) Cash Burn Rate

Full year 2022 earnings released: AU$0.007 loss per share (vs AU$0.004 loss in FY 2021)

Optiscan Imaging Limited, Annual General Meeting, Nov 24, 2022

Optiscan Submits FDA 510(k) Application for InVivage Device

Insider recently bought AU$1.9m worth of stock

Optiscan Imaging Limited Appointment of Sean Gardiner as Non-Executive Director

We're Not Very Worried About Optiscan Imaging's (ASX:OIL) Cash Burn Rate

Less than half of directors are independent

Insider recently bought AU$1.2m worth of stock

Insider recently bought AU$1.4m worth of stock

Optiscan Imaging (ASX:OIL) Is In A Strong Position To Grow Its Business

Full year 2021 earnings released: AU$0.004 loss per share (vs AU$0.004 loss in FY 2020)

Non-Executive Director Graeme Mutton has left the company

We're Not Worried About Optiscan Imaging's (ASX:OIL) Cash Burn

Optiscan Imaging Limited Announces Update on seeking United States FDA approval & market entry

How Much Of Optiscan Imaging Limited (ASX:OIL) Do Insiders Own?

New 90-day high: AU$0.23

Optiscan Imaging Limited Announces Appointment of Ron Song as New Non-Executive Director

Optiscan Imaging Limited Announces Commencement of Stage Three of its Breast Cancer Study in Melbourne

OptiScan Imaging Limited Receives Orders from Carl Zeiss Meditec AG

Can You Imagine How Jubilant Optiscan Imaging's (ASX:OIL) Shareholders Feel About Its 253% Share Price Gain?

Optiscan Imaging Limited Announces US FDA Regulatory Approval Update

Optiscan Imaging Limited announced that it expects to receive AUD 9.813499 million in funding from Orchid Fund Pte. Limited and other investors

Optiscan Imaging Limited Auditor Raises 'Going Concern' Doubt

Full year earnings released - AU$0.0037 loss per share

Optiscan Image Ltd Ordinary Shares to Be Deleted from Other OTC

수익 및 비용 분석

수익 및 매출 내역

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

자기자본 수익률

자산 수익률

고용 자본 수익률

과거 성과가 우수한 기업 찾기